Titan Pharmaceuticals
Price & Volume
Stats
See more52W Range | $3.23-$14.80 |
Market Cap | $3.3M |
Shares Short | 9,132 |
Financials
See moreRevenue (12 Mos) | $3,000 |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | -$4.3M |
Diluted EPS | -$6.64 |
News
See moreYahoo Finance • last year
Titan Pharmaceuticals Announces Appointment of Dato' Seow Gim Shen and Brynner Chaim to the Company's Board of Directors
Yahoo Finance • last year
Titan Pharmaceuticals Announces $9.5 Million Private Placement of Convertible Preferred Stock
Yahoo Finance • 2 years ago
Titan Pharmaceuticals Provides Shareholder Update
Yahoo Finance • 2 years ago
UPDATE -- Titan Pharmaceuticals Inc. Announces Licensing Agreement with Ocular Therapeutix Inc.
About
CEO | Jennifer Kiernan |
Address | 400 Oyster Point Boulevard, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 4 |
